Wiener Biometrische Sektion

Kolloquien Seminar Geschichte Statuten Mitgliedschaft Vorstand&Impressum

Programm 2017

Programm 2016

Programm 2015

Programm 2014

Programm 2013

Programm 2012

Programm 2011

Programm 2010

Programm 2009

Programm 2008

Programm 2007

Programm 2006

Programm 2005

Programm 2004

Programm 2003

Programm 2002

Programm 2001

Programm 2000

Programm 1999

Programm 2017:

28. September, Andrew Vickers (Memorial Sloan-Kettering Cancer Center)
How Do we Know Whether a Predictive Model is of Clinical Value? How Do we Know Whether a Molecular Marker is Worth Measuring? A Discussion of Some Simple Decision Analytical Methods 

7. September, Chris Jennison (University of Bath)
Data Combination in Seamless Phase II/III Clinical Trial Designs

22. Mai, Sarah Zohar (INSERM, Paris)
Bayesian Treatment Comparison Using Parametric Mixture Priors Computed from Elicited Histograms 

20. April, Marius Thomas (Novartis)
Exploratory Subgroup Analyses in Clinical Trials 

20. März, R.A. Bailey (University of St. Andrews)
Hasse Diagrams as an Aid to Understanding a Family of Models in Experiments on Biodiversity 

13. März, Rok Blagus (University of Ljubljana)
Cumulative Sum Processes for Goodness-of-Fit Testing

21. Februar, Ioannis Kosmidis (University College London)
Reduced‐Bias Inference for Regression Models with Tractable and Intractable Likelihoods

20. Februar, Mathias Schmid (Rheinische Friedrich‐Wilhelms‐Universität Bonn)
Modeling Discrete Time-to-Event Data

14. Februar, Thomas Jaki (Lancaster University)
Multi-Objective Dose-Finding

26. Jänner, Karel G.M. Moons, Geert-Jan Geersing (UMC Utrecht)
Clinical Prediction Models: Don't Develop Them!
Managing Venous Thrombosis in Primary Care Medicine (SLIDES_Moons(SLIDES_Geersing)

17. Jänner, Efstathia Bura (Washington DC)
Sufficient Reductions in Regression and Classification 

12. Jänner, Helene Jacqmin-Gadda (INSERM, France)
Target Estimands in a Longitudinal Study with Follow-up Truncated by Death and Dropout

9. Jänner, Ludwig A. Hothorn (Leibniz Universität Hannover)
Ein universeller Trendtest? Welche Kriterien sollte ein universeller Trendtest erfüllen? 


Programm 2016:

16. Dezember, Stefan Michiels (Université Paris-Saclay)
Calculating Expected Survival from High-Dimensional Cox Models with Treatment-by-Marker Interactions in Randomized Clinical Trials

18. November, Tim Friede (University Medical Center Göttingen)
Some Statistical Aspects of Clinical Trials for Personalized  Medicine

14. November, Silke Jörgens (ICON, Köln)
Confirmatory Adaptive Group Sequential Trials: Treatment Arm and Subpopulation Selection Based on Surrogate Endpoints (SLIDES)

10. Oktober, Eva Schernhammer (Med. Universität Wien)
Angewandte Epidemiologie in der Prävention von Chronischen Erkrankungen: die Nurses’ Health Studie

22. September, Malgorzata Bogdan (University of Wroclaw)
Identifying Genetic Factors Influencing Important Patient Characteristics

1. August, Mariana Nold (Universitätsklinikum Jena)
A Comparison of Two Approaches for Meta-Analysis of Individual Patient Data

19. Juli, Livio Finos (University of Padua)
A Graphical Approach to Resampling Based Multiple Testing Procedures

20. Mai, Lisa Hampson (Lancaster University)
Optimal Group Sequential Tests for Delayed Responses with Non-Binding Futilitiy Boundaries

20. Mai, Ekkehard Glimm (Novartis)
Some Updates on Weighted Parametric Tests

19. Mai, Daniel Commenges (University of Bordeaux)
The Stochastic System Approach to Causality

14. April,  WBS Festsymposium
25 Jahre Klinische Biometrie

4. April,  Tyler VanderWeele (Havard School of Public Health)
Workshop with Tyler VanderWeele:
Lecture "A unification of mediation and interaction: a four-way decomposition" and Q&A session

21. März,  Aliaksandr Hubin (University of Oslo)
Variable selection in logistic regression with a latent Gaussian
field models with an application in epigenomics

18. März,  Geert Verbeke and Geert Molenberghs (KU Leuven, Hasselt University)
Diagnostics for mixed models: two approaches

26. Jänner,  Nils Ternés (Université Paris-Sud, Université Paris-Saclay)
Identification of biomarker-by-treatment interactions in randomized clinical trials with survival outcomes and high-dimensional spaces

18. Jänner,  Ulrike Schneider (TU Wien)
Statistical Inference after Lasso Estimation

13. Jänner,  Andreas Futschik (Johannes Kepler Universität Linz)
On the inadmissibility of common population genetic estimates and their improvement by using shrinkage

Programm 2015:

12. November,  Ludwig Hothorn (Leibniz University Hannover, Germany)
Simultaneous inference using multiple marginal models in R (MMM)

17. September, Florian Klinglmüller (University of Padua, Department of Statistics)
Permutation Tests for Adaptive Clinical Trial Designs 

9. Juni, Xavier Paoletti (Biostatistics and epidemiology / INSERM U1018)
Dose finding on repeated measurements in oncology phase I clinical trials 

4. Mai Arne Bathke (Universität Salzburg)
Trying to Make Sense of Multivariate Data Samples Using Different Inferential Methods

27. April, Søren Möller (University of Southern Denmark, Odense)
Methods for calculating heritability of diseases estimated from large twin studies

17. März, Toshifumi Sugitani (Medical University of Vienna)
Flexible alpha allocation strategies for confirmatory adaptive enrichment clinical trials with a pre-specified subgroup

Programm 2014:

17. November, 15:30 (s.t.) Ludwig Hothorn
Quality ranking or ... comparisons against the grand mean 

29. Oktober, 16:30 (s.t.) Bernhard Klingenberg

A new and improved confidence interval for the Mantel-Haenszel risk differences

6. Oktober, 16:30 (s.t.) Geraldine Rauch
Challenges of Composite Endpoints - New methods to overcome planning, analysis and interpretation problems

18. Juni, 11:00 (s.t.) Alex Dmitrienko
Mixture-based multiple testing procedures: The good, the bad and the ugly

28. April, 10:00 (s.t.) Holger Dette

Optimal design for dose finding studies with an active control

25. März, 16:00 (s.t.) Zoran Antonijevic
Optimizing Clinical Outcomes Using Simulations In Modern Drug Development

12. Februar, 14:00 (s.t.) Tanja Stamm
PatientInnenperspektive und Biomarker - wie hängen diese zusammen?

Programm 2013:

16. Dezember, 16:30 (s.t.) Karl Schlag
Exact Nonparametric Binary Choice and Ordinal Regression Analysis

5. Dezember, 16:30 (s.t.) Alexandra Posekany
Improving robustness and reliability of bioinformatical inference

3. Dezember, 14:0 (s.t.) Frank Konietschke
Nonparametric multiple comparison procedures under heteroscedasticity

23. Oktober, 15:00 (s.t.) Open Access to Clinical Trial Data -
Opportunities, challenges and risks of sharing clinical trial data on patient level (Panel Discussion, joint event with MUW and Pharmig)


21. Oktober, 16:15 (s.t.) Ludwig Hothorn
User-defined contrasts within multiple contrast tests - case  studies

26. September, 16:15 (s.t.) Gregory Nuel
Simulation of phenotypes under H1 in Genome Wide
Association studies and applications

17. Juni, 16:30 (s.t.) Gernot Wassmer
Enrichment Designs: Methoden und Anwendungen
Adaptive Verfahren zur Selektion von Studienpopulationen - DOWNLOAD SLIDES

6. Juni, 16:00 (s.t.) Dominic Magirr

Flexible Sequential Designs for Multi-Arm Clinical Trials - DOWNLOAD SLIDES

13. Mai, 16:30 (s.t.) Gerhard Hommel
Multiple test procedures using ordered p-values - DOWNLOAD - SLIDES

8. Mai, 16:30 (s.t.) Caroline Uhler
Chromosome Packing in Cell Nucleus - DOWNLOAD - SLIDES

30. Jänner, 14:30 (s.t.) Andreas Ziegler
Personalized Medicine using DNA Biomarkers - DOWNLOAD - SLIDES

24. Jänner, 16:30 (s.t.) Frank Miller
Sample size Re-estimation and Bias - DOWNLOAD - SLIDES

21. Jänner, 11:00 (s.t.) Cécile Proust-Lima

Joint modelling of multivariate longitudinal mixed outcomes and a time-to-event: a latent variable approach - DOWNLOAD - SLIDES

17. Jänner, 11:00 (s.t.) David Azriel 

Adaptive designs to maximize power  in clinical trials with multiple treatments - DOWNLOAD - SLIDES

Programm 2012:

10. Dezember, 13:00 (s.t.) Ronald Geskus

Inverse probability weighted  estimators in a competing risks setting: analyses can be performed with standard software

9. November 2012, 10:30 (s.t.) Milan Stehlík

Cancer risk assessment: Fractals versus Stochastics

12. Juli 2012, 10:00 (s.t.) Malgorzata Bogdan

Logic Regression for Localizing Interacting Quantitative Trait Loci

21. Mai 2012, 14:00 (s.t.) Janez Stare

A Measure of Explained Variation for Event History Data

10. Mai 2012, 13:30 (s.t.) Karen Leffondré

Comparison of the illness-death model and standard survival models for interval-censored data: a simulation study and an application to dementia

12. April 2012, 16:00 (s.t.) Alan Hubbard

Semiparametric Variable Importance Estimation: machine learning and causal inference for estimating the relative "importance” of many competing predictors

26. März 2012, 14:00 (s.t.) Manuela Zucknick

Integration of multiple genomic data sources in Bayesian Regression Models for Prediction and Biomarker Selection

22. Februar 2012, 10:00 (s.t.) Jeannette Klimont, Barbara Leitner und Nadine Zielonke


17. Jänner 2012, 11:00 (s.t.) Alain Hauser

Causal inference from interventional data


Programm 2011:

18. Oktober 2011, 16:00 (s.t.) Dominic Magir

Design and Analysis of Multi‐Arm, Multi‐Stage Clinical Studies

18. Oktober 2011, 11:00 (s.t.) Dimitris Rizopoulos

Joint Models for Longitudinal and Event Time Data, and Dynamic Predictions

7. Oktober 2011, 10:00 (s.t.) Markus Bauer

Computational challenges in next-generation DNA sequencing

23. Mai 2011, 11:30 (s.t.) Willi Sauerbrei

Towards stratified medicine – instead of dichotomization, estimate a treatment effect function for a continuous covariate

5. Mai 2011, 16:00 (s.t.) Martin Wolfsegger

Assessing Systemic Drug Exposure in Repeated Dose Toxicity Studies in the Case of Complete and Incomplete Sampling

19. April 2011, 15:00 (s.t.) Frank Bretz

Graphical approaches to multiple test procedures,

On the efficiency of two-stage adaptive designs

31. März 2011, 15:00 (s.t.) Patrick Royston

A new strategy for meta-analysis of continuous covariates in observational studies

18. Jänner 2011, 10:30 (s.t.) Jenö Reiczigel

Estimation of prevalence and relative risk in case of an imperfect test


Programm 2010:

2. Dezember 2010, 14:00 (s.t.) Thomas Hielscher

Cox PH penalized regression models in high-dimensional data: model fit, model assessment and sample size considerations

8. September 2010, 14:00 (s.t.) Terry Therneau

Practical Mixed-Effects Survival Models

29. Juni 2010, 10:30 (s.t.) Michal Abrahamowicz

Flexible joint modelling of cumulative and non-linear effects of time-varying risk factors on the hazard

22. Juni 2010, 10:30 (s.t.) Bernhard Klingenberg

Simultaneous confidence bounds in multiple comparisons to control (Foto)

21. Juni 2010, 13:00 (s.t.) Helmut Finner

On the false discovery rate and control of expected number of false rejections

7. Juni 2010, 14:00 (s.t.) Dr. Linda Beale

The UK Small Area Health Statistics Unit: approaches to spatial epidemiology

28. Mai 2010, 14:00 (s.t.) Prof. Catherine Legrand

Generalized conditional linear models with time varying coefficients under right censoring: practical implementation and extensions (Foto)

11. Mai 2010, 11:00 (s.t.) Prof. Sven Ove Samuelsen

Case-cohort and Nested case-control studies: differences and similarities (Foto)

14. April 2010, 10:45 (s.t.) Dr. Herwig Friedl

Schätzung von Dunkelziffern mit Applikationen im Bereich der Kriminologie und der Epidemiologie


Programm 2009:

12. November 2009, 15:00 (s.t.) Dr. Florian Frommlet

Asymptotic optimality of multiple testing and model selection procedures under sparsity

8. Oktober 2009, 11:00 (s.t.) Dr. Amel Mahboubi

Validation of a new flexible method for modelling of the effects of continuous prognostic factors in relative survival

31. August 2009, 16:00 (s.t.) Prof. Chihiro Hirotsu

Row-wise multiple comparison approach to the analysis of two-way interaction with particular interest in the ordered rows and/or columns

22. Juni 2009, 11:00 (s.t.) Prof. Leonhard Held

INLA in action: Bayesian inference without tears?

25. Mai 2009, 14:00 (s.t.) Dr. Helga Wagner

Stochastic model specification search for state space and dynamic survival models

20. Mai 2009, 16:00 (s.t.) Dr. Alex Dmitrienko

Multi-stage gatekeeping procedures with clinical trials applications

18. Mai 2009, 16:00 (s.t.) Prof. William Rosenberger

Inference for Randomized Clinical Trials

19. März 2009, 15:00 (s.t.) Prof. Dankmar Böhning

Meta-Analysis of Diagnostic Studies by Means of (S)ROC-Modelling – a Profile-likelihood Approach based on the Lehmann-family


Programm 2008:

20. Oktober 2008, 16:00 (s.t.) Dr. Zachary Skrivanek

A Seamless 2/3 Design Incorporating a Clinical Utility Index

15. Mai 2008, 15:30 PD Dr. Achim Zeileis

A Lego System for Conditional Inference

14. April 2008, 16:00 Prof. Dr. Andreas Futschik

Statistical Methods for Quantitative Trait Localization Based on Genome Data

28. Jänner 2008, 15:30 Dr. Frank Bretz

Ordered Multiple Comparisons with the Best and Their Applications to Dose–Response Studies

17. Jänner 2008, 15:00 Ass. Prof. Dr. Karl Moder

A new approach to evaluate interaction in block design

11. Jänner 2008, 15:00 (s.t.) Dr. Lara Lusa

Filtering Enhanced Feature Selection: A Multiple Testing Strategy for the Identification of Differentially Expressed Features in High-Dimensional Data Sets


Programm 2007:

6. Dezember 2007, 15:00 Dipl. Ing. Bernhard Spangl

Estimating Spectral Density Functions Robustly

7. November 2007, 15:30 (s.t.) Dr. Willi Maurer

Sources of Multiplicty in Adptive Designs

18. Oktober 2007, 15:00 Prof. Dr. Rob Verdooren

Der Wilcoxon-Zweistichproben-Test für gruppierte Daten und ein Nicht-Standard-SPSS-Programm

11. Oktober 2007, 16:00 Ass. Prof. Berhard Klingenberg

Testing dose-response with multivariate ordinal data

16. Mai 2007, 14:00 Dr. Marc Vandemeulebroecke

A general approach to two-stage tests

20. März 2007, 16:00 Dr. Gerhard Svolba

Data Preparation for Analytics

13. Februar 2007, 16:00 Prof. Dr. Fátima Sánchez-Cabo

Statistical aspects and medical applications of „-omics“ data integration

23. Jänner 2007, 15:00 Prof. Nigel Stallard and Dr. Tim Friede

A group-sequential method for clinical trials with treatment selection (Nigel Stallard)

Blinded sample size reestimation in non-inferiority trials with binary
endpoints (Tim Friede)

18. Jänner 2007, 16:00 Prof. Dieter Rasch

Wie viele Individuen benötigt man zur Schätzung populationsgenetischer Parameter?

16. Jänner 2007, 16:00 Prof. Dieter Rasch

Inwieweit sind statistische Verfahren anwendbar wenn Voraussetzungen zu deren Herleitung verletzt sind?


Programm 2006:

16. Novermber 2006, 13:30 Mag. Maja Pohar

Regression in Relative Survival using R

20. Oktober 2006, 14:00 Prof. David Kreil

RNA expression profiling with microarrays - Interplay of experiments and analysis

13. Juni 2006, 15:30 Mag. Thomas Lang

Arzneimittelzulassung in der EU - Regulatorische Rahmenbedingungen und Möglichkeiten der Mitwirkung von nationalen Experten in Beratungs- und Zulassungsverfahren

27. März 2006, 14:00 Prof. Dr. Gernot Wassmer

On Estimation in Adaptive Survival Trials

13. März 2006, 14:00 Doz. Dr. Frank Bretz

Combining Multiple Comparisons and Modeling Techniques in Dose Response Studies

6. März 2006, 17:30 Mag. Siegfried Hörmann

Modellierung und Prognose der Feinstaubkonzentration in Graz

23. Februar 2006, 14:00 s.t. Dr. Stefan Michiels

Issues in the prediction of cancer outcome with microarrays

16. Januar 2006, 11:30 s.t. Prof. Dr. Arndt Peter von Haeseler

Stochastic Models of Sequence Evolution


Programm 2005

10. November 2005, 13:30 s.t. Dr. Daniele De Martini

Estimating Sample Size and Reproducibility for Nonparametric Statistical Tests

27. Oktober 2005, 15:00 s.t. Mag. Franz König

Zwischenergebnisse, Flexibilität und Ineffizienz

29. Juli 2005, 11:00 s.t. Dr. Carina Ittrich

Penalized Maximum Likelihood Regression

16. Juni 2005, 16:15 Dr. Gregor Laaha

Regionalisierung von Niederwasserkennwerten für Einzugsgebiete österreichischer Fließgewässer

9. Juni 2005, 14:00 s.t. Dr. Yasemin Genç

Closed Form Methods to Compare Two Proportions for Clustered Data

3. Mai 2005, 16:00 Mag. Margit Ehrenmüller und Mag. Johannes Dobretsberger

Analysieren und planen von med. Studien mit SAS Enterprise Guide und SAS/STAT Power and Sample Size Application. Ein praxisorientierter Überblick mit Demonstrationen

27. April 2005, 16:15 Dipl. Ing. Bernhard Spangl

On Robust Spectral Density Estimation with Applications to the Analysis of Heart Rate Variability cities

28. Februar 2005, 10:30 s.t Dr. Daniel Rabczenko

Estimation of short-term effect of air pollution on mortality based on distributed lag models and dose-response analysis - Results from four Polish cities


Programm 2004

15. Dezember 2004, 16:15 Herr Dipl.Ing Richard Petritsch

Anwendung und Validierung des Klimainterpolationsmodells DAYMET in Österreich

11. November 2004, 15:00 s.t. Frau Prof. Malinee Laopaiboon

Meta-analyses involving cluster randomization trials: a review of published literature in health care

14. Oktober 2004, 16:00 Herr Dr. Friedrich Leisch

R: Freie Software für Statistische Datenanalyse und Graphik

21. Juni 2004, 16:00 Herr Prof. William F. Rosenberger

Maximizing Power and Minimizing Treatment Failures in Clinical Trials

26. Mai 2004, 16:30 Frau Dipl.Ing. Barbara Kavsek

PLS (Partial Least Squares) Regression und ihre Anwendungen

29. April 2004, 16:00 Herr Prof. K.-D. Wernecke

A Mixed Model Approach to Discriminant Analysis with Longitudinal Data

24. Februar 2004, 17:35  Frau Mag. Margit Ehrenmüller

SAS Enterprise Guide : Statistische Auswertungen für Nichtstatistiker in der Medizin


Programm 2003

6. Oktober 2003, 16:15  Prof. Dr. Tze Leung Lai:

Power, sample size and adaptation considerations in the design of group sequential trials.

11. April 2003, 10:30   Prof. Dr. John Nelder:

Extended likelihood inference applied to a new class of models.

1. April 2003, 16:30  Prof. Dr. Kurt Hornik:

Neurale Netze und Biostatistik (Folien zum Vortrag)

23. Jänner 2003, 16:15  Prof. Dr. Albrecht Neiß:

Biometrisches Zentrum für Multiple Sklerose-Forschung.

20. Jänner 2003, Dr. Anette Kopp-Schneider (Heidelberg):

Stochastische Modelle für die Hepatokarzinogenese.


Programm 2002

11. Dezember 2002, 16:15 Prof. Dr. Marcus Hudec (Wien):


27. November 2002, 16:00  Ph.Lic. Sharon Kühlmann (Göteborg):

A matched case-control study in the forest: influence of trees on undestory vegetation.

27. September 2002, 10:30  Prof. Dr. Albrecht Neiß (München):

Biometrisches Zentrum für Multiple Sklerose-Forschung

12. Juni 2002, 16:00  Dr. Alexander Ploner:

Modellieren von Besucherzahlen mit Regressionsbäumen

22. Mai 2002, 16:00 Prof. Dr. Werner G. Müller:

Residualdiagnostik für Variogrammschätzung

24. Jänner 2002, 16:00 Prof. Patrick Royston:

Flexible parametric models for censored survival data, with application to prognostic modelling and estimation of treatment effects

16. Jänner 2002, 16:00 Prof. Dr. Christine Mannhalter:

Durchführung und Einsatzgebiete von Gen-Chip Analysen (Microarrays)

11. Jänner 2002, 15:00 Prof. David Firth:

Maximum likelihood estimates: bias, finiteness, shrinkage


Programm 2001

13.Juni 2001, 16:15 Prof. Dr. Thomas Waldhör:

Aus der räumlichen Epidemiologie

31. Jänner 2001, 16:15: Prof.Dr. Christine Mannhalter:

Molekularbiologische Untersuchungen in der Medizin - Grundlagen für Statistiker 


Programm 2000

08. November 2000, 16:15: Alessandra Nardi University of Teramo and University of Vienna

On residuals analysis for survival data

11.Oktober 2000, 16:30: Prof. Dr. Christine Mannhalter:

Molekularbiologische Untersuchungen in der Medizin - Grundlagen für Statistiker

06.März 2000, 16:st.: Werner Brannath:

Monotone Confidence Bounds in Adaptive Two Stage Combination Tests

25. Jänner 2000, 16:00 s.t. : Hubert Hasenauer:

Die simultanen Eigenschaften von Waldwachstumsmodellen


Programm 1999

13. Dezember 1999, 16:00: Erika Graf:

Schätzung des Vorhersagefehlers in der Überlebenszeitanalyse 

23. Nov.1999, 16:00: Helmut Finner:

Stichprobenumfangsbestimmungen für Mehrentscheidungsverfahren: Probleme, Methoden und ein Softwarepaket

4. Mai 1999, 16:00: John Whitehead:

1. Sequential designs for comparative clinical trials
2. Sequential trials with more than two treatments or more than one endpoint

15. April 1999, 16:00: Fulvio De Santis:

Recent Issues in Bayesian Model Selection